Аронов Д. М., Бубнова М. Г. Клинические эффекты статинов: фокус на симвастатин. Кардиоваскулярная терапия и профилактика. 2009;8(2):75-81.
1. Драпкина О.М., Клименков А.В., Суховская И.И., Ивашкин В.Т. Опыт применения симвастатина у пациентов с заболеваниями печени. Кардиоваск тер профил 2007; 6(5): 70—5.
2. Карпов Р.С., Кошельская О.А., Суслова Е.У. и др. Влияние 6-месячной терапии симвастатином на липидтранспортную функцию крови и состояние эндотелия у пациентов с сахарным диабетом и артериальной гипертензией. Кардиология 2006; 1: 27—31.
3. Мясников А.Л. “Гипертоническая болезнь и атеросклероз” Москва “Медицина” 1965.
4. POSCH Group. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. NEJM 1990; 323: 946-55.
5. de Divitiis M, Pubba P, Ей Sommas S, et al. Effects ofshort-term reduction in serum cholesterol with simvastatin in patients with stable angina pectoris and mild to moderate hypercholesterolemia. Am J Cardiol 1996; 78: 763-8.
6. Calmer PL, Berge KG, Wenger NK, et al. for the Coronary Drug Project Research Group. Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. JACC 1986; 8: 1243-55.
7. Corsini A New insights into statins: on anti-atherosclerotic mechanism and drag interaction In Direct anti-atherosclerotic effects at statins: from experimental evidence to clinical benefit. A satellite Symposium of the XIII International Symposium on drug Affecting Lipid Metabolism. 1998, Florence, Italy.
8. Low MR, Wald NJ, Thomson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischemic heart disease? BMJ 1994; 308: 367-72.
9. MAAS investigators. Effect of simvastatin on coronary atheroma: the multicentre anti-atheroma study (MAAS). Lancet 1994; 344: 633-8.
10. Pedersen T, Olsson AG, Faergeman O, et al. for The Scandinavian Simvastatin Survival Study Group. Lipoprotein changes and reduction in the incidence of major coronary heart disease events in The Scandinavian Simvastatin Survival Study (4S). Circulation 1998; 97: 1453-60.
11. Scandinavion Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-9.
12. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomized placebocontrolled trial. Lancet 2002, 360: 7—22.
13. Home BD, Vuhlestein JB, Carlquist JF, et al. Statin thetapy, lipid levels, C-reactive protein and survival of patients with angiographically severe coronary artery disease. JACC 2000; 36(6): 1774-80.
14. Диагностика и лечение больных острым инфарктом миокарда с подъемом сегмента ST электрокардиограммы. Российские рекомендации. Москва 2007; 120 с.
